Cellebrite Marcus Jewell plans sale of 1,045 shares

The notice ties the sale solely to income-tax liabilities incurred when restricted share unit awards vested.

Available on EDGAR 11/10/2026 - 06:16 AM EST Accepted by SEC EDGAR 11/10/2026 - 06:16 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Marcus Jewell, Cellebrite DI Ltd.'s Officer, Global Chief Revenue Officer, intends to sell 1,045 common shares, with an approximate sale date of November 12, 2026. The listed aggregate market value is $13,271.5. The shares were acquired through restricted share units vested under an issuer S-8 registered plan on November 11, 2026.

The planned sale is under a mandatory, non-discretionary sell-to-cover arrangement solely to satisfy income tax liabilities incurred upon vesting of restricted share unit awards.

Key Figures

Shares to be sold: 1,045 shares Aggregate market value: $13,271.5 Shares outstanding: 251,341,060 shares +2 more

5 metrics

Shares to be sold 1,045 shares Approximate sale date November 12, 2026

Aggregate market value $13,271.5 Shares to be sold

Shares outstanding 251,341,060 shares Number listed in the securities information

Prior sale 411 shares Sale on August 12, 2026; gross proceeds $6,603.86

Prior sale 12,562 shares Sale on August 21, 2026; gross proceeds $141,216.97

Key Terms

sell-to-cover arrangement, restricted share units, S-8 Registered Plan

3 terms

sell-to-cover arrangement financial

"mandatory, non-discretionary, sell-to-cover arrangement"

restricted share units financial

"Restricted Share Units Vested Under an Issuer S-8 Registered Plan"

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

S-8 Registered Plan regulatory

"vested under an issuer S-8 registered plan"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CLBT shares does Marcus Jewell plan to sell?

Marcus Jewell intends to sell 1,045 common shares, with an approximate sale date of November 12, 2026 and a listed aggregate market value of $13,271.5. The notice describes the transaction as a mandatory, non-discretionary sell-to-cover arrangement for income tax liabilities incurred upon vesting of restricted share unit awards only.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001875661
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Cellebrite DI Ltd.
SEC File Number	001-40772
Address of Issuer	94 SHLOMO SHMELZER ROAD PETAH TIKVA ISRAEL 4970602
Phone	972733948000
Name of Person for Whose Account the Securities are To Be Sold	Marcus Jewell
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer, Global Chief Revenue Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1045	13271.5	251341060	11/12/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary shares, par value NIS 0.00001	11/11/2026	Restricted Share Units Vested Under an Issuer S-8 Registered Plan	Cellebrite DI Ltd.			1045	11/11/2026	Employee Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Marcus H Jewell 94 Shlomo Shmelzer Road Petah Tikva L3 4970602	Common	08/12/2026	411	6603.86
Marcus H Jewell 94 Shlomo Shmelzer Road Petah Tikva L3 4970602	Common	08/21/2026	12562	141216.97

144: Remarks and Signature

Remarks	The reporting person intends to sell securities reported herein on 11/12/2026 pursuant to a mandatory, non-discretionary, sell-to-cover arrangement for the purposes of satisfying income tax liabilities incurred upon vesting of restricted share unit awards only.
Date of Notice	11/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Marcus Jewell
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)